BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15526803)

  • 1. Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis.
    Luppi F; Cerri S; Beghè B; Fabbri LM; Richeldi L
    Respir Med; 2004 Nov; 98(11):1035-44. PubMed ID: 15526803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory agents for idiopathic pulmonary fibrosis.
    Davies HR; Richeldi L; Walters EH
    Cochrane Database Syst Rev; 2003; (3):CD003134. PubMed ID: 12917947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic pulmonary fibrosis: current and future treatment options.
    Davies HR; Richeldi L
    Am J Respir Med; 2002; 1(3):211-24. PubMed ID: 14720059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids for idiopathic pulmonary fibrosis.
    Richeldi L; Davies HR; Ferrara G; Franco F
    Cochrane Database Syst Rev; 2003; 2003(3):CD002880. PubMed ID: 12917934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of pulmonary fibrosis].
    Cottin V
    Presse Med; 2002 Oct; 31(34):1613-23. PubMed ID: 12426980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?
    Luppi F; Cerri S; Richeldi L
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S74-84. PubMed ID: 16457019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary fibrosis.
    Balamugesh T; Behera D
    J Assoc Physicians India; 2007 May; 55():363-70. PubMed ID: 17844698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug treatments for idiopathic pulmonary fibrosis].
    Crestani B; Marchand-Adam S; Schneider S
    Rev Pneumol Clin; 2005 Jun; 61(3):221-31. PubMed ID: 16142196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids in idiopathic pulmonary fibrosis.
    Lynch JP; White E; Flaherty K
    Curr Opin Pulm Med; 2001 Sep; 7(5):298-308. PubMed ID: 11584180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroid agents for idiopathic pulmonary fibrosis.
    Spagnolo P; Del Giovane C; Luppi F; Cerri S; Balduzzi S; Walters EH; D'Amico R; Richeldi L
    Cochrane Database Syst Rev; 2010 Sep; (9):CD003134. PubMed ID: 20824834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment guidelines on the initial management of idiopathic pulmonary fibrosis.
    Munson JC; Kreider M; Chen Z; Christie JD; Kimmel SE
    Br J Clin Pharmacol; 2010 Jul; 70(1):118-25. PubMed ID: 20642554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary fibrosis--a therapeutic dilemma?].
    Günther A; Markart P; Eickelberg O; Seeger W
    Med Klin (Munich); 2006 Apr; 101(4):308-12. PubMed ID: 16607487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials of investigational agents for IPF: a review of a Cochrane report.
    Richeldi L
    Respir Res; 2013; 14 Suppl 1(Suppl 1):S4. PubMed ID: 23734867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term development of idiopathic pulmonary fibrosis. Combined therapy with immunodepressors, D-penicillamine and corticosteroids].
    Meier-Sydow J; Connette B; Hübel E; Kroidl RF; Kronenberger H; Müller U; Rust M; Thiel C
    Bronchopneumologie; 1979; 29(3):249-54. PubMed ID: 509328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Idiopathic pulmonary fibrosis: should corticoids still be used? Which immunosuppressive agent, for how long?].
    Crestani B
    Rev Mal Respir; 2004 Feb; 21(1):209-10. PubMed ID: 15260069
    [No Abstract]   [Full Text] [Related]  

  • 17. Current and future treatment options in idiopathic pulmonary fibrosis.
    Hauber HP; Blaukovitsch M
    Inflamm Allergy Drug Targets; 2010 Jul; 9(3):158-72. PubMed ID: 20518722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic clues in idiopathic pulmonary fibrosis].
    Todea D; Corhuţ S
    Pneumologia; 2002; 51(3):222-9. PubMed ID: 12602095
    [No Abstract]   [Full Text] [Related]  

  • 19. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
    Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
    Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic pulmonary fibrosis. A rational clinical approach.
    Raghu G
    Chest; 1987 Jul; 92(1):148-54. PubMed ID: 3297516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.